Model
Edge
Moonlake Immunotherapeutics
0001920553
Filing Type
4
Filing Date
2/28/2024
Updated
2/29/24, 12:53 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership